-For symptom control of all forms of malaria
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>Artesunate</strong> is a semi-synthetic derivative of artemisinin, widely recognized as a first-line treatment for severe malaria. Manufactured via chemical modification to enhance water solubility, its molecular formula is C₁₉H₂₈O₈ and CAS number is 84512-90-3.</p>
<h3>Application</h3>
<ul>
<li><strong>Antimalarial Therapy:</strong> Intravenous or intramuscular administration for severe Plasmodium falciparum infections.</li>
<li><strong>Combination Therapies:</strong> Key component in Artemisinin-based Combination Therapies (ACTs) for uncomplicated cases.</li>
<li><strong>Research:</strong> Investigated for potential anti-cancer and immunomodulatory properties in clinical trials.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly contraindicated during the first trimester of pregnancy due to teratogenic risks. Requires storage in cool, dry conditions below 25°C away from direct sunlight. Medical supervision is mandatory to prevent delayed hemolysis post-treatment.</p>